ROBERT L. VAN NOSTRAND - 24 May 2021 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
Director
Signature
/s/ Megan N. Gates, attorney-in-fact
Issuer symbol
YTEN
Transactions as of
24 May 2021
Net transactions value
$0
Form type
4
Filing time
26 May 2021, 09:59:46 UTC
Next filing
22 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 24 May 2021 Common Stock 5,000 $7.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were issued to the Reporting Person as the annual option grant to non-employee directors pursuant to the Issuer's Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors and/or a committee thereof.
F2 These options will vest and become exercisable in equal quarterly installments over 4 years from 5/24/2021, beginning on 8/24/2021 and ending on 5/24/2025.